Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.

Wu, Xing

Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas. [electronic resource] - Journal of neuro-oncology Apr 2016 - 221-32 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1573-7373

10.1007/s11060-015-2039-z doi


AC133 Antigen--genetics
Adolescent
Adult
Aged
Biomarkers, Tumor--genetics
Brain Neoplasms--genetics
Child
Child, Preschool
DNA Methylation
Female
Follow-Up Studies
Glioma--genetics
Humans
Immunoenzyme Techniques
Male
Middle Aged
Neoplasm Grading
Neoplastic Stem Cells--metabolism
Prognosis
Promoter Regions, Genetic--genetics
Survival Rate
Young Adult